These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17632319)

  • 1. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer.
    Crous-Bou M; Porta M; López T; Jariod M; Malats N; Alguacil J; Morales E; Fernandez E; Corominas JM; Carrato A; Guarner L; Real FX;
    Pancreas; 2007 Aug; 35(2):135-41. PubMed ID: 17632319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma.
    Crous-Bou M; Porta M; López T; Jariod M; Malats N; Morales E; Guarner L; Rifà J; Carrato A; Real FX;
    Environ Mol Mutagen; 2009 Jun; 50(5):421-30. PubMed ID: 19326463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative influence of diet and serum concentrations of organochlorine compounds on K-ras mutations in exocrine pancreatic cancer.
    Gasull M; Porta M; Pumarega J; Vioque J; Bosch de Basea M; Puigdomènech E; Morales E; Grimalt JO; Malats N
    Chemosphere; 2010 Apr; 79(7):686-97. PubMed ID: 20350743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.
    Slebos RJ; Hoppin JA; Tolbert PE; Holly EA; Brock JW; Zhang RH; Bracci PM; Foley J; Stockton P; McGregor LM; Flake GP; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1223-32. PubMed ID: 11097231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study.
    Crous-Bou M; Porta M; Morales E; López T; Carrato A; Puigdomènech E; Real FX;
    Cancer Causes Control; 2009 Jul; 20(5):591-9. PubMed ID: 19083106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
    Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT
    Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and K-ras mutations in lung cancers from former and never-smoking women.
    Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
    Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
    Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
    Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study.
    Weijenberg MP; Aardening PW; de Kok TM; de Goeij AF; van den Brandt PA
    Mutat Res; 2008 Mar; 652(1):54-64. PubMed ID: 18296105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution.
    Soliman AS; Lo AC; Banerjee M; El-Ghawalby N; Khaled HM; Bayoumi S; Seifeldin IA; Abdel-Aziz A; Abbruzzese JL; Greenson JK; Hamilton SR
    Carcinogenesis; 2007 Aug; 28(8):1794-9. PubMed ID: 17575320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer.
    Alguacil J; Porta M; Kauppinen T; Malats N; Kogevinas M; Carrato A;
    Int J Cancer; 2003 Nov; 107(4):635-41. PubMed ID: 14520703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
    Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
    Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk.
    Lo AC; Soliman AS; El-Ghawalby N; Abdel-Wahab M; Fathy O; Khaled HM; Omar S; Hamilton SR; Greenson JK; Abbruzzese JL
    Pancreas; 2007 Aug; 35(2):120-9. PubMed ID: 17632317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes.
    Porta M; Crous-Bou M; Wark PA; Vineis P; Real FX; Malats N; Kampman E
    Mutat Res; 2009; 682(2-3):83-93. PubMed ID: 19651236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
    Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
    Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.
    Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA
    Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
    Porta M; Malats N; Guarner L; Carrato A; Rifà J; Salas A; Corominas JM; Andreu M; Real FX
    J Epidemiol Community Health; 1999 Nov; 53(11):702-9. PubMed ID: 10656099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators.
    Malats N; Porta M; Corominas JM; Piñol JL; Rifà J; Real FX
    Int J Cancer; 1997 Mar; 70(6):661-7. PubMed ID: 9096646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attributable risks for pancreatic cancer in northern Italy.
    Fernandez E; La Vecchia C; Decarli A
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):23-7. PubMed ID: 8770462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 alterations in bladder tumors from arsenic and tobacco exposed patients.
    Moore LE; Smith AH; Eng C; DeVries S; Kalman D; Bhargava V; Chew K; Ferreccio C; Rey OA; Hopenhayn C; Biggs ML; Bates MN; Waldman FM
    Carcinogenesis; 2003 Nov; 24(11):1785-91. PubMed ID: 12919957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.